SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 16, 2005
Commission File Number 1-09623
IVAX CORPORATION
Florida 16-1003559
- ------------------------------- ---------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
4400 Biscayne Boulevard, Miami, Florida 33137
---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
(305) 575-6000
--------------
(Registrant's telephone number, including area code)
Check the appropriate box if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (See General Instruction A.2. below):
[_] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 13e-4(c))
Item 5.02 Departure of Directors or principal Officers; Election of Directors;
Appointment of Principal Officers.
On February 16, 2005 Richard M. Krasno Ph.D. was nominated and appointed to the
board of directors of IVAX Corporation. On February 16, 2005, Dr. Krasno's
appointment was announced by IVAX in a press release which is attached hereto as
Exhibit 99.1 and incorporated by reference herein.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
IVAX Corporation
Date: February 16, 2005 By: /s/Thomas E. Beier
--------------------------------
Thomas E. Beier
Senior Vice President-Finance
Chief Financial Officer